Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05627947

Comparison Between Topical Mitomycin C and Cyclosporine

Conditions: Pterygium

Sex: All
Ages: 45 Years – 65 Years
Phase: PHASE1
Enrollment: 57
Sponsor: Egymedicalpedia

Location: Egypt

Summary

Pterygium is a disease associated with proliferation of the fibrovascular tissues of the conjunctiva into the cornea and is related to factors such as ultraviolet light exposure, chronic stimulation, inflammation, climate, and genetics.

Eligibility Criteria

Inclusion Criteria:Diagnosis of primary pterygiumPterygium size > or equal 2mm (the horizontal length of the tissue from limbus to cornea will be measured by slit lamp biomicroscopy).Ocular discomfort refractory to medical treatment.Visual loss induced by pterygium.Adult Egyptian populationExclusion Criteria:Patients who had recurrent pterygium or allergy to topical Cyclosporine.Patients who had allergy from Mitomycin C.Pregnant women.Patients with uncontrollable systemic diseases such as hypertension, diabetes, or cardiovascular diseases.Patients with diseases of the eye surface such as conjunctivitis and keratitis.Patients with a history of eye surgery within the previous six months.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05627947). StuddyBuddy aggregates publicly available trial information.